Want to see OTLC full AI Analyst Report?
Oncotelic Therapeutics (OTLC) Ownership - Who Owns Oncotelic Therapeutics?
Oncotelic Therapeutics (OTLC) Ownership Overview
- 26.85% Insiders
- 73.15% Public Companies and Individual Investors
The ownership structure of Oncotelic Therapeutics (OTLC) stock is a mix of institutional, retail, and individual investors. , 26.85% is owned by Insiders, and 73.15% is owned by Public Companies and Individual Investors.
The ownership structure of Oncotelic Therapeutics (OTLC) stock is a mix of institutional, retail, and individual investors. , 26.85% is owned by Insiders, and 73.15% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|---|---|---|
| Oct 29, 2026 | Vuong Trieu | $13,570 | |
| Jun 23, 2026 | Vuong Trieu | $10,200 | |
| Jun 21, 2026 | Amit B. Shah | $1,000 | |
| Jun 16, 2026 | Vuong Trieu | $13,430 |
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vuong Trieu | 119,134,222 | Insider | 26.04% | 1,906,148 |
| Steven W. King | 3,330,647 | Insider | 0.73% | 53,290 |
| Amit B. Shah | 378,837 | Insider | 0.08% | 6,061 |
FAQ
What percentage of Oncotelic Therapeutics (OTLC) stock is held by retail investors?
According to the latest TipRanks data, approximately 73.15% of Oncotelic Therapeutics (OTLC) stock is held by public companies and individual investors.
Who owns the most shares of Oncotelic Therapeutics (OTLC)?
Vuong Trieu owns the most shares of Oncotelic Therapeutics (OTLC).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.